Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 51-58 , January 2007

Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients

  • Claudia R.L. Cardoso
    • ,
  • Gil F. Salles

      Affiliations

    • Corresponding Author InformationCorresponding author at: Rua Croton 72, Jacarepaguá, CEP 22750-240, Rio de Janeiro, Brazil. Tel.: +55 21 24473577; fax: +55 21 22702193.

Received 20 April 2006 ,Accepted 20 April 2006.

References 

  1. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes. Diabetes Care. 2002;25:43–48
  2. Muggeo M, Verlato G, Bonora E, Bressan F, Giorotto S, Corbellini M, et al. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia. 1995;38:318–325
  3. Morrish NJ, Wang S-L, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(Suppl. 2):S14–S21
  4. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes Care. 1998;21:1138–1145
  5. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infection in patients with diabetes. New Engl. J. Med. 1999;341:1906–1912
  6. Bertoni AG, Saydah S, Brancati F. Diabetes and the risk of infection-related mortality in the US. Diabetes Care. 2001;24:1044–1049
  7. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl. J. Med. 1997;336:243–250
  8. Leibovici L, Drucker M, Konigsberger H, Sumra Z, Harrari S, Ashkenazi S, et al. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand. J. Infect. Dis. 1997;29:71–75
  9. Pozilli P, Leslie RDG. Infection and diabetes: mechanisms and prospects for prevention. Diabet. Med. 1994;11:935–941
  10. Salles GF, Bloch K, Cardoso C. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care. 2004;27:1299–1305
  11. Cardoso C, Salles G, Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J. Diabetes Complicat. 2003;17:169–178
  12. Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int. J. Cardiol. 2001;79:253–262
  13. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings, Standards and Procedures for Measurement and Classification. Littleton, MA: J. Wright; 1982;
  14. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure, the Framingham study. New Engl. J. Med. 1971;285:1441–1449
  15. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analysis. Am. J. Epidemiol. 1995;142:1255–1264
  16. Concato J, Feinstein AR, Holford TR. The risk of determining risk in multivariate models. Ann. Intern. Med. 1993;118:201–210
  17. Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. J. Public Health. 1999;89:1715–1721
  18. Wang SL, Head J, Stevens L, Fuller JH. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The Who Organization Multinational Study of Vascular Disease in Diabetes. Diabetes Care. 1996;19:305–312
  19. Florkowski CM, Scott RS, Coope PA, Moir CL. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a 10-year cohort study. Diabetes Res. Clin. Pract. 2001;53:113–120
  20. Orth SR, Ritz E. Medical progress: the nephrotic syndrome. New Engl. J. Med. 1998;338:1202–1211
  21. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–513
  22. Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care. 2004;27:1605–1609
  23. Moss SE, Klein R, Klein BEK. Cause-specific mortality in a population-based study of diabetes. Am. J. Public Health. 1991;81:1158–1162
  24. Leelawattana R, Rattarasarn C, Lim A, Soonthornpun S, Setasuban W. Causes of death, incidence and risk factors of cardiovascular disease in Thai type 2 diabetic patients: a 5-year follow-up study. Diabetes Res. Clin. Pract. 2003;60:183–189
  25. Benavides FG, Bolumar F, Peris R. Quality of death certificates in Valencia, Spain. Am. J. Public Health. 1989;79:1352–1354
  26. Pinner K, Tetutsh SM, Simonsen L, Kluf LA, Graber JM, Clarke MJ, et al. Trends in infectious disease mortality in the United States. JAMA. 1996;275:189–193
  27. Kuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am. J. Epidemiol. 1992;135:638–648

PII: S0168-8227(06)00163-X

doi: 10.1016/j.diabres.2006.04.008

Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 51-58 , January 2007

Article Tools

* Image Usage & Resolution